<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Written Evidence Submitted by Professor Peter Gill</title></head><body><div><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:center"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">Written Evidence s</span><span style="font-family:Calibri; font-size:11pt; font-weight:bold">ubmitted by Professor Peter Gill</span><span style="font-family:Calibri; font-size:11pt; font-weight:bold"> (FSS037)</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">Declaration of Interests</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt">See previous submission: </span><a href="http://www.publications.parliament.uk/pa/cm201012/cmselect/cmsctech/855/855vw19.htm"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.publications.parliament.uk/pa/cm201012/cmselect/cmsctech/855/855vw19.htm</span></a></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">Current</span><span style="font-family:Calibri; font-size:11pt; font-weight:bold"> position</span><span style="font-family:Calibri; font-size:11pt; font-weight:bold">:</span><span style="font-family:Calibri; font-size:11pt"> I am Professor of Forensic Genetics at the Norwegian Institute of Public health and the University of Oslo, Norway.  Previously, I was principle research scientist at the FSS research laboratories for a period of 25 years (1982-2008).</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt">C.V.is available at: </span><a href="https://sites.google.com/site/peterdgill/"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">https://sites.google.com/site/peterdgill/</span></a></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">International interests:</span><span style="font-family:Calibri; font-size:11pt"> </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt">1)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">I am member of the EU-FP7 (security)  funded </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">EUROFORGEN</span><span style="font-family:Calibri; font-size:11pt"> network of excellence</span><span style="font-family:Calibri; font-size:11pt"> </span><a href="http://euroforgen.com/"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://euroforgen.com/</span></a><span style="font-family:Calibri; font-size:11pt">  and I am responsible for coordinating research activities within workpackage 3.  </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt">2)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">I chair the</span><span style="font-family:Calibri; font-size:11pt; font-style:italic"> ISFG DNA commission </span><a href="http://www.isfg.org/Working%20Groups/DNA%20Commission"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.isfg.org/Working%20Groups/DNA%20Commission</span></a><span style="font-family:Calibri; font-size:11pt"> which is responsible for publishing standards and guidelines for practitioners</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt">3)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">I chair the </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">ENFSI</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">methods, analysis and Interpretation and subgroup</span><span style="font-family:Calibri; font-size:11pt"> (part of the DNA working group) – also responsible for providing practitioners with standards and best practice guidelines: </span><a href="http://www.enfsi.eu/about-enfsi/structure/working-groups/dna"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.enfsi.eu/about-enfsi/structure/working-groups/dna</span></a></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">Research interests:</span><span style="font-family:Calibri; font-size:11pt"> </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt">1)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">I work primarily on the interpretation and statistics of DNA profiling evidence. I specialise in supporting the development of open-source software to interpret complex mixtures see: </span><a href="http://forensim.r-forge.r-project.org/"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://forensim.r-forge.r-project.org/</span></a><span style="font-family:Calibri; font-size:11pt"> . In addition, current interests include writing a major review, based on recent incidents, on the causes of Miscarriages of Justice. See my website for details of current activities, latest publications and information on training courses: </span><a href="https://sites.google.com/site/forensicdnastatistics/"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">https://sites.google.com/site/forensicdnastatistics/</span></a></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">Summary of my scientific output:</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Calibri; font-size:11pt">Publications and statistics are available at: </span><a href="http://scholar.google.com/citations?user=Ba1THJYAAAAJ&amp;hl=en"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://scholar.google.com/citations?user=Ba1THJYAAAAJ&amp;hl=en</span></a></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Calibri; font-size:11pt">Summary:</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 54pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt">a)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">188 publications</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 54pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt">b)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">No. of citations (how many times my publications have been cited by other workers)=10,700 </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 54pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt">c)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">My h-index = 58</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">What impacts have the FSS closure had?</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt"><span style="font-family:Calibri; font-size:11pt; font-style:italic">Britain demonstrably lags behind the rest of Europe – international credibility is seriously damaged.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">1)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">The FSS ranked 5</span><span style="font-family:Calibri; font-size:7.33pt; vertical-align:super">th</span><span style="font-family:Calibri; font-size:11pt"> in the world in terms of scientific citations </span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_1"><span style="font-family:Calibri; font-size:11pt">1</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt">.  </span><span style="font-family:Calibri; font-size:11pt">No other laboratory in the UK features </span><span style="font-family:Calibri; font-size:11pt">as a world class </span><span style="font-family:Calibri; font-size:11pt">laboratory devoted</span><span style="font-family:Calibri; font-size:11pt"> to forensic science.</span><span style="font-family:Calibri; font-size:11pt"> In addition</span><span style="font-family:Calibri; font-size:11pt">, England</span><span style="font-family:Calibri; font-size:11pt"> and Wales</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">are</span><span style="font-family:Calibri; font-size:11pt"> the only </span><span style="font-family:Calibri; font-size:11pt">countries</span><span style="font-family:Calibri; font-size:11pt"> in Europe without a national forensic science centre.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">2)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">The rest of Europe has implemented new marker systems based on the </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">European Standard Set of Markers</span><span style="font-family:Calibri; font-size:11pt"> recommended by the European Network of Forensic Science Institutes </span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_2"><span style="font-family:Calibri; font-size:11pt">2</span></a><span style="font-family:Calibri; font-size:11pt">,</span><a href="#_ENREF_3"><span style="font-family:Calibri; font-size:11pt">3</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt">(ENFSI)</span><span style="font-family:Calibri; font-size:11pt"> and adopted by the EU commission</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt">UK appears to be isolated in Europe by failing to move this project forward within the time-scales suggested by the EU. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">3)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">The new systems have much more powerful discriminating power and are able to analyse highly degraded </span><span style="font-family:Calibri; font-size:11pt">and compromised </span><span style="font-family:Calibri; font-size:11pt">samples</span><span style="font-family:Calibri; font-size:11pt"> (not possible with current system in use)</span><span style="font-family:Calibri; font-size:11pt">.</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">UK </span><span style="font-family:Calibri; font-size:11pt">is </span><span style="font-family:Calibri; font-size:11pt">currently </span><span style="font-family:Calibri; font-size:11pt">locked into</span><span style="font-family:Calibri; font-size:11pt"> outdated technology that is more than ten years old</span><span style="font-family:Calibri; font-size:11pt">.</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">This means that c</span><span style="font-family:Calibri; font-size:11pt">ases will not be </span><span style="font-family:Calibri; font-size:11pt">analysed using </span><span style="font-family:Calibri; font-size:11pt">best practice methods</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt">Cross </span><span style="font-family:Calibri; font-size:11pt">-</span><span style="font-family:Calibri; font-size:11pt">border comparisons with other countries </span><span style="font-family:Calibri; font-size:11pt">will be</span><span style="font-family:Calibri; font-size:11pt"> compromised since the systems in use will no longer be entirely compa</span><span style="font-family:Calibri; font-size:11pt">rable</span><span style="font-family:Calibri; font-size:11pt">.</span><span style="font-family:Calibri; font-size:11pt"> Is there a timetable for UK introduction?</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">Impact of FSS closure on quality</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt"><span style="font-family:Calibri; font-size:11pt; font-style:italic">Notable high profile errors have occurred</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">4)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">The New Scientist anonymous survey </span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_4"><span style="font-family:Calibri; font-size:11pt">4</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt"> was strong evidence that there is concern from employees within the UK laboratories. More than three quarters of respondents believed that there was significant risk of miscarriages of justice within the current system. It is highly significant that two high profile errors were identified </span><span style="font-family:Calibri; font-size:11pt">a matter of weeks </span><span style="font-family:Calibri; font-size:11pt; text-decoration:underline">after</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">the prophetic </span><span style="font-family:Calibri; font-size:11pt">publication of the New Scientist report (see next section). The New Scientist survey demonstrated the importance of discovering the morale and opinions of </span><span style="font-family:Calibri; font-size:11pt">employees. </span><span style="font-family:Calibri; font-size:11pt">In the interests of restoring public confidence, I would recommend that a new survey is initiated to discover if the position has improved. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">5)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">The loss of quality predicted by the New Scientist review came to fruition with two high profile cases </span><span style="font-family:Calibri; font-size:11pt"> in: </span><span style="font-family:Calibri; font-size:11pt">‘wrongful arrest of Adam Scott’</span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_5"><span style="font-family:Calibri; font-size:11pt">5</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt"> and the </span><span style="font-family:Calibri; font-size:11pt">contamination event combined with a </span><span style="font-family:Calibri; font-size:11pt">transposition error in </span><span style="font-family:Calibri; font-size:11pt">‘Death of </span><span style="font-family:Calibri; font-size:11pt">Gareth Williams</span><span style="font-family:Calibri; font-size:11pt">’</span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_6"><span style="font-family:Calibri; font-size:11pt">6</span></a><span style="font-family:Calibri; font-size:11pt">,</span><a href="#_ENREF_7"><span style="font-family:Calibri; font-size:11pt">7</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt">. Both errors were the result of </span><span style="font-family:Calibri; font-size:11pt">bad practice (clearly not following international guidelines</span><span style="font-family:Calibri; font-size:11pt"> e.g.</span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_8"><span style="font-family:Calibri; font-size:11pt">8</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">) </span><span style="font-family:Calibri; font-size:11pt">– </span><span style="font-family:Calibri; font-size:11pt"> in particular, </span><span style="font-family:Calibri; font-size:11pt">ignoring negative controls that give DNA profiles (Scott); failure to check results before uploading to the national DNA database (Williams</span><span style="font-family:Calibri; font-size:11pt">).</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt"><span style="font-family:Calibri; font-size:11pt; font-style:italic">A zero error rate is scientifically untenable</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">6)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">The regulator review was critical of the offending laboratory but </span><span style="font-family:Calibri; font-size:11pt">suggested</span><span style="font-family:Calibri; font-size:11pt"> that no further contamination incidents </span><span style="font-family:Calibri; font-size:11pt">were</span><span style="font-family:Calibri; font-size:11pt"> present in a batch of 26,000 samples</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">7)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">Further work is needed, however. </span><span style="font-family:Calibri; font-size:11pt">To clarify the position: </span><span style="font-family:Calibri; font-size:11pt">t</span><span style="font-family:Calibri; font-size:11pt">he</span><span style="font-family:Calibri; font-size:11pt">re is no test for contamination (the effect is hidden) </span><span style="font-family:Calibri; font-size:11pt">and it is not possible to equate </span><span style="font-family:Calibri; font-size:11pt">the</span><span style="font-family:Calibri; font-size:11pt"> (presumed)</span><span style="font-family:Calibri; font-size:11pt"> regulator’s view of </span><span style="font-family:Calibri; font-size:11pt">‘</span><span style="font-family:Calibri; font-size:11pt">absence of evidence</span><span style="font-family:Calibri; font-size:11pt">’</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">with ‘evidence of absence’.  </span><span style="font-family:Calibri; font-size:11pt">In a</span><span style="font-family:Calibri; font-size:11pt"> (contradictory) </span><span style="font-family:Calibri; font-size:11pt"> piece of work to understand the mechanisms and impact of contamination</span><span style="font-family:Calibri; font-size:11pt">,</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">Gill </span><span style="font-family:Calibri; font-size:11pt">and Kirkham</span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_9"><span style="font-family:Calibri; font-size:11pt">9</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">, working under FSS auspices</span><span style="font-family:Calibri; font-size:11pt">,</span><span style="font-family:Calibri; font-size:11pt"> showed that it was possible to estimate contamination rates, but </span><span style="font-family:Calibri; font-size:11pt">it is </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">not</span><span style="font-family:Calibri; font-size:11pt"> possible to identify </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">which</span><span style="font-family:Calibri; font-size:11pt"> samples were contaminated. </span><span style="font-family:Calibri; font-size:11pt">A review carried out under FSS auspices on a typical casework process demonstrated a contamination rate </span><span style="font-family:Calibri; font-size:11pt">of 1 in 1000 samples analysed</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">Not all contamination events lead to errors of interpretation, however</span><span style="font-family:Calibri; font-size:11pt; font-style:italic">[</span><a href="#_ENREF_9"><span style="font-family:Calibri; font-size:11pt; font-style:italic">9</span></a><span style="font-family:Calibri; font-size:11pt; font-style:italic">]</span><span style="font-family:Calibri; font-size:11pt; font-style:italic">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">8)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">A</span><span style="font-family:Calibri; font-size:11pt"> zero error rate for commercial providers</span><span style="font-family:Calibri; font-size:11pt"> is scientifically untenable</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">(</span><span style="font-family:Calibri; font-size:11pt">note that the statistic quoted in Scott was 1 in 1 billion, and ignored the possibility of error</span><span style="font-family:Calibri; font-size:11pt">)</span><span style="font-family:Calibri; font-size:11pt">. There needs to be </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">pro-active</span><span style="font-family:Calibri; font-size:11pt"> assessment of error rates that </span><span style="font-family:Calibri; font-size:11pt">should</span><span style="font-family:Calibri; font-size:11pt"> be disclosed and published.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">What should be the role of the forensic science regulator?</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">9)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt">Clearly the regulator role </span><span style="font-family:Calibri; font-size:11pt">can</span><span style="font-family:Calibri; font-size:11pt">not </span><span style="font-family:Calibri; font-size:11pt">properly function</span><span style="font-family:Calibri; font-size:11pt"> in isolation but needs to be part of a coherent centralised organisation that is devoted to forensic science. </span><span style="font-family:Calibri; font-size:11pt">In previous submissions to the committee I recommended that the </span><span style="font-family:Calibri; font-size:11pt">core functions: research, regulation/accreditation, </span><span style="font-family:Calibri; font-size:11pt">and </span><span style="font-family:Calibri; font-size:11pt">standards</span><span style="font-family:Calibri; font-size:11pt">,</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">were</span><span style="font-family:Calibri; font-size:11pt"> subsumed and coordinated centrally </span><span style="font-family:Calibri; font-size:11pt">by</span><span style="font-family:Calibri; font-size:11pt"> a national centre of excellence</span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_10"><span style="font-family:Calibri; font-size:11pt">10</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">Forensic science is rapidly changing and improving. This means that there needs to be a mechanism in place to implement research into casework </span><span style="font-family:Calibri; font-size:11pt">– implementation</span><span style="font-family:Calibri; font-size:11pt"> needs to be simultaneous across UK laboratories. </span><span style="font-family:Calibri; font-size:11pt">This is difficult to achieve within a highly fragmented environment. </span><span style="font-family:Calibri; font-size:11pt">T</span><span style="font-family:Calibri; font-size:11pt">he </span><span style="font-family:Calibri; font-size:11pt">necessary </span><span style="font-family:Calibri; font-size:11pt">infrastructure required to validate and </span><span style="font-family:Calibri; font-size:11pt">to </span><span style="font-family:Calibri; font-size:11pt">implement new technology to the same standards across providers does not </span><span style="font-family:Calibri; font-size:11pt">currently </span><span style="font-family:Calibri; font-size:11pt">exist</span><span style="font-family:Calibri; font-size:11pt">.</span><span style="font-family:Calibri; font-size:11pt">  </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Calibri; font-size:11pt; font-style:italic">The way forward</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Calibri; font-size:11pt; font-style:italic; font-weight:bold">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">10)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:Calibri; font-size:11pt">W</span><span style="font-family:Calibri; font-size:11pt">e </span><span style="font-family:Calibri; font-size:11pt">must </span><span style="font-family:Calibri; font-size:11pt">accept that the FSS (as it existed) was no longer fit for purpose, but </span><span style="font-family:Calibri; font-size:11pt">it seems obvious that the core functions could have been preserved in a national centre of excellence</span><span style="font-family:Calibri; font-size:11pt"> (UK could also have retained its international ra</span><span style="font-family:Calibri; font-size:11pt">n</span><span style="font-family:Calibri; font-size:11pt">king and associated credibility by this route)</span><span style="font-family:Calibri; font-size:11pt">. This course of action would have resulted in divestment of routine casework activities to commercial organisations, but the new centre would have retained the ability to carry out analysis of complex casework requiring novel technology that </span><span style="font-family:Calibri; font-size:11pt">is not used by any commercial provider. This is because the profit motive precludes use of any technique that </span><span style="font-family:Calibri; font-size:11pt">is loss-making</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt">This has resulted in a </span><span style="font-family:Calibri; font-size:11pt">rapidly growing technology-gap </span><span style="font-family:Calibri; font-size:11pt">in the UK. For example implementation of </span><span style="font-family:Calibri; font-size:11pt">latest </span><a name="_GoBack"></a><span style="font-family:Calibri; font-size:11pt">new body fluid markers (RNA), mitochondrial DNA analysis; Y chromosome analysis; informative SNP ancestry markers are not in routine use</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">11)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:Calibri; font-size:11pt">There is a concern that the Home Office exerts undue influence over the regulator and the role should be remote and independent from </span><span style="font-family:Calibri; font-size:11pt">this government body</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt"> Otherwise conflict of interest may arise.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">12)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:Calibri; font-size:11pt">There is a concern that the regulator role is restricted to committee discussions without the necessary resources to implement recommendations</span><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">13)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:Calibri; font-size:11pt">There should be much more focus on discovery of error rates and limitations of evidence. The information should be in the public domain.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">14)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:Calibri; font-size:11pt">As a prime example: t</span><span style="font-family:Calibri; font-size:11pt">here needs to be much more </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">pro-active</span><span style="font-family:Calibri; font-size:11pt"> assessment of laboratories to prevent errors </span><span style="font-family:Calibri; font-size:11pt">occurring</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">Note that the laboratory involved with the Scott and Williams cases was fully accredited by the authorities, but this did not prevent catastrophic failure. </span><span style="font-family:Calibri; font-size:11pt">The </span><span style="font-family:Calibri; font-size:11pt">regulator </span><span style="font-family:Calibri; font-size:11pt">response to the </span><span style="font-family:Calibri; font-size:11pt">Scott case </span><span style="font-family:Calibri; font-size:11pt">was</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">mainly </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">re</span><span style="font-family:Calibri; font-size:11pt; font-style:italic">-</span><span style="font-family:Calibri; font-size:11pt; font-style:italic">active</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt">However, we must recognise that t</span><span style="font-family:Calibri; font-size:11pt">here is an implied </span><span style="font-family:Calibri; font-size:11pt">weakness </span><span style="font-family:Calibri; font-size:11pt">within the </span><span style="font-family:Calibri; font-size:11pt">accreditation</span><span style="font-family:Calibri; font-size:11pt">/regulatory process </span><span style="font-family:Calibri; font-size:11pt">itself </span><span style="font-family:Calibri; font-size:11pt">in that it failed to detect major deviance from acceptable laboratory practice</span><span style="font-family:Calibri; font-size:11pt"> in the first place</span><span style="font-family:Calibri; font-size:11pt"> . </span><span style="font-family:Calibri; font-size:11pt">In a recent review by Gill et al</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">[</span><a href="#_ENREF_11"><span style="font-family:Calibri; font-size:11pt">11</span></a><span style="font-family:Calibri; font-size:11pt">]</span><span style="font-family:Calibri; font-size:11pt">, under </span><span style="font-family:Calibri; font-size:11pt">UK </span><span style="font-family:Calibri; font-size:11pt">regulator auspices, </span><span style="font-family:Calibri; font-size:11pt">it was proposed to develop three over-arching ‘assessor’ roles</span><span style="font-family:Calibri; font-size:11pt"> (if properly resourced, this will  begin to address the concerns)</span><span style="font-family:Calibri; font-size:11pt">. The new roles are</span><span style="font-family:Calibri; font-size:11pt">:</span></p><ol type="a" style="margin:0pt; padding-left:0pt"><ol type="a" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 67.05pt; padding-left:4.95pt; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Setting technical standards</span></li><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 67.56pt; padding-left:4.44pt; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">To monitor that standards are achieved</span></li><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 66.43pt; padding-left:5.57pt; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">To set</span><span style="font-family:Calibri; font-size:11pt"> and to evaluate on-going compe</span><span style="font-family:Calibri; font-size:11pt">tency (for example) assessment via proficiency testing</span></li></ol></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-indent:-18pt"><span style="font-family:Calibri; font-size:11pt; font-style:normal">15)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:Calibri; font-size:11pt">However, s</span><span style="font-family:Calibri; font-size:11pt">ignificant resources are required to implement the points above (in a purely commercial environment this is quite challenging</span><span style="font-family:Calibri; font-size:11pt">).</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">Also this is further evidence of the need for a UK centre of excellence to take over the combined roles of research/implementation/ standards etc.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">List of references</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_1"><span style="font-family:Calibri; font-size:11pt">[1]</span></a><a href="http://www.researchresearch.com/index.php?option=com_news&amp;template=rr_2col&amp;view=article&amp;articleId=1085593"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.researchresearch.com/index.php?option=com_news&amp;template=rr_2col&amp;view=article&amp;articleId=1085593</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_2"><span style="font-family:Calibri; font-size:11pt">[2] </span></a><a href="http://www.ncbi.nlm.nih.gov/pubmed/22658771"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.ncbi.nlm.nih.gov/pubmed/22658771</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_3"><span style="font-family:Calibri; font-size:11pt">[3] </span></a><a href="http://www.enfsi.eu/"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.enfsi.eu/</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_4"><span style="font-family:Calibri; font-size:11pt">[4] </span></a><a href="http://www.newscientist.com/article/mg21328514.600-forensic-failure-miscarriages-of-justice-will-occur.html"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.newscientist.com/article/mg21328514.600-forensic-failure-miscarriages-of-justice-will-occur.html</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_5"><span style="font-family:Calibri; font-size:11pt">[5] </span></a><a href="http://www.homeoffice.gov.uk/publications/agencies-public-bodies/fsr/dna-contam-report?view=Binary"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.homeoffice.gov.uk/publications/agencies-public-bodies/fsr/dna-contam-report?view=Binary</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_6"><span style="font-family:Calibri; font-size:11pt">[6] </span></a><a href="http://www.bbc.co.uk/news/uk-17826633"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.bbc.co.uk/news/uk-17826633</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_7"><span style="font-family:Calibri; font-size:11pt">[7] </span></a><a href="http://en.wikipedia.org/wiki/Death_of_Gareth_Williams"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://en.wikipedia.org/wiki/Death_of_Gareth_Williams</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_8"><span style="font-family:Calibri; font-size:11pt">[8]</span></a><a href="http://www.enfsi.eu/sites/default/files/documents/bylaws/guidance_document_for_best_practice_manuals.pdf"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.enfsi.eu/sites/default/files/documents/bylaws/guidance_document_for_best_practice_manuals.pdf</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_9"><span style="font-family:Calibri; font-size:11pt">[9]</span></a><a href="http://projects.nfstc.org/workshops/resources/literature/Amplification/27_Development%20of%20a%20Simulation%20Model%20to%20Assess%20the.pdf"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://projects.nfstc.org/workshops/resources/literature/Amplification/27_Development%20of%20a%20Simulation%20Model%20to%20Assess%20the.pdf</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-indent:-36pt"><a name="_ENREF_10"><span style="font-family:Calibri; font-size:11pt">[10] </span></a><a href="http://www.publications.parliament.uk/pa/cm201012/cmselect/cmsctech/855/855vw19.htm"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.publications.parliament.uk/pa/cm201012/cmselect/cmsctech/855/855vw19.htm</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 10pt 36pt; text-indent:-36pt"><a name="_ENREF_11"><span style="font-family:Calibri; font-size:11pt">[11] </span></a><a href="http://www.homeoffice.gov.uk/publications/agencies-public-bodies/fsr/interpretation-of-dna-evidence?view=Binary"><span style="color:#0000ff; font-family:Calibri; font-size:11pt; text-decoration:underline">http://www.homeoffice.gov.uk/publications/agencies-public-bodies/fsr/interpretation-of-dna-evidence?view=Binary</span></a><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Calibri; font-size:11pt; font-style:italic">January 2013</span></p></div></body></html>